BIOC
Biocept, Inc.
stock NASDAQ

$GALT is going to the fucking moon. High volume High increase!
a buyout could make it hit 20
insider increased shares from 200k to 1m. FDA approval soon, no competition.
They said the 36 month data is on trend with the previous data but they didn't publish, likely rumored due to being in negoitations with a buyer.
the company has the safest and only drug likely to be approved by FDA. 18+ billion peak sales yearly. If its true then it'd skyrocket easily.
they have to publish the data within two weeks.
Examples of buyouts with prices similar to $GALT before the buyout occurred:
Arena Pharmaceuticals (ARNA): ~$1.50 to $100 (2021, Pfizer).
BioClinica (BIOC): ~$0.70 to $12 (2013, JLL Partners).
Dyax Corp (DYAX): ~$1.80 to $37.30 (2015, Shire).
InterMune (ITMN): ~$1.60 to $74 (2014, Roche). Achillion Pharmaceuticals (ACHN): ~$1 to $6 (2020, Alexion buyout).
Endocyte (ECYT): ~$1 to $24 (2018, Novartis buyout).
Pharmacyclics (PCYC): <$1 to $261 (2015, AbbVie buyout).
Trillium Therapeutics (TRIL): $0.23 to $18.50 (2022, Pfizer buyout).

$GALT is going to the fucking moon. High volume High increase!
a buyout could make it hit 20
insider increased shares from 200k to 1m. FDA approval soon, no competition.
They said the 36 month data is on trend with the previous data but they didn't publish, likely rumored due to being in negoitations with a buyer.
the company has the safest and only drug likely to be approved by FDA. 18+ billion peak sales yearly. If its true then it'd skyrocket easily.
they have to publish the data within two weeks.
Examples of buyouts with prices similar to $GALT before the buyout occurred:
Arena Pharmaceuticals (ARNA): ~$1.50 to $100 (2021, Pfizer).
BioClinica (BIOC): ~$0.70 to $12 (2013, JLL Partners).
Dyax Corp (DYAX): ~$1.80 to $37.30 (2015, Shire).
InterMune (ITMN): ~$1.60 to $74 (2014, Roche). Achillion Pharmaceuticals (ACHN): ~$1 to $6 (2020, Alexion buyout).
Endocyte (ECYT): ~$1 to $24 (2018, Novartis buyout).
Pharmacyclics (PCYC): <$1 to $261 (2015, AbbVie buyout).
Trillium Therapeutics (TRIL): $0.23 to $18.50 (2022, Pfizer buyout).